[Des-Arg9]-BRADYKININ (BioDeep_00001028751)

   


代谢物信息卡片


(Des-Arg9)-Bradykinin acetate salt

化学式: C44H61N11O10 (903.4603)
中文名称: 血管舒缓激肽片段1-8,醋酸盐水合物
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: C1CC(N(C1)C(=O)C2CCCN2C(=O)C(CCCN=C(N)N)N)C(=O)NCC(=O)NC(CC3=CC=CC=C3)C(=O)NC(CO)C(=O)N4CCCC4C(=O)NC(CC5=CC=CC=C5)C(=O)O
InChI: InChI=1S/C44H61N11O10/c45-29(15-7-19-48-44(46)47)40(61)55-22-10-18-35(55)42(63)54-21-8-16-33(54)38(59)49-25-36(57)50-30(23-27-11-3-1-4-12-27)37(58)52-32(26-56)41(62)53-20-9-17-34(53)39(60)51-31(43(64)65)24-28-13-5-2-6-14-28/h1-6,11-14,29-35,56H,7-10,15-26,45H2,(H,49,59)(H,50,57)(H,51,60)(H,52,58)(H,64,65)(H4,46,47,48)/t29-,30-,31-,32-,33-,34-,35-/m0/s1

描述信息

同义名列表

2 个代谢物同义名

(Des-Arg9)-Bradykinin acetate salt; [Des-Arg9]-BRADYKININ



数据库引用编号

4 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。

亚细胞结构定位 关联基因列表


文献列表

  • Tanja Gangnus, Bjoern B Burckhardt. Targeted LC-MS/MS platform for the comprehensive determination of peptides in the kallikrein-kinin system. Analytical and bioanalytical chemistry. 2021 May; 413(11):2971-2984. doi: 10.1007/s00216-021-03231-9. [PMID: 33693976]
  • Mehrdad Alikhani, Amir Javadi, Mahdi Aalikhani. Des-Arg9 bradykinin and bradykinin potentially trigger cytokine storm in patients with COVID-19. Iranian journal of immunology : IJI. 2021 03; 18(1):93-94. doi: 10.22034/iji.2021.89684.1962. [PMID: 33787518]
  • Steven de Maat, Quirijn de Mast, A H Jan Danser, Frank L van de Veerdonk, Coen Maas. Impaired Breakdown of Bradykinin and Its Metabolites as a Possible Cause for Pulmonary Edema in COVID-19 Infection. Seminars in thrombosis and hemostasis. 2020 10; 46(7):835-837. doi: 10.1055/s-0040-1712960. [PMID: 32526773]
  • Joseph A Roche, Renuka Roche. A hypothesized role for dysregulated bradykinin signaling in COVID-19 respiratory complications. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2020 06; 34(6):7265-7269. doi: 10.1096/fj.202000967. [PMID: 32359101]
  • Xu Qian, Duc T M Nguyen, Yaojun Li, Jianxin Lyu, Edward A Graviss, Tony Y Hu. Predictive value of serum bradykinin and desArg9-bradykinin levels for chemotherapeutic responses in active tuberculosis patients: A retrospective case series. Tuberculosis (Edinburgh, Scotland). 2016 12; 101S(?):S109-S118. doi: 10.1016/j.tube.2016.09.022. [PMID: 27720377]
  • Haiyan Wu, Anton J M Roks, Frank P J Leijten, Ingrid M Garrelds, Usha M Musterd-Bhaggoe, Antoon J van den Bogaerdt, Moniek P M de Maat, Maarten L Simoons, A H Jan Danser, Hisko Oeseburg. Genetic variation and gender determine bradykinin type 1 receptor responses in human tissue: implications for the ACE-inhibitor-induced effects in patients with coronary artery disease. Clinical science (London, England : 1979). 2014 Mar; 126(6):441-9. doi: 10.1042/cs20130204. [PMID: 24117346]
  • Kevser Erol, Basar Sirmagul, Fatma Sultan Kilic, Semra Yigitaslan, Ali Evrim Dogan. The role of inflammation and COX-derived prostanoids in the effects of bradykinin on isolated rat aorta and urinary bladder. Inflammation. 2012 Apr; 35(2):420-8. doi: 10.1007/s10753-011-9331-7. [PMID: 21537904]
  • Rafael L Pereira, Bruna N Buscariollo, Matheus Corrêa-Costa, Patricia Semedo, Cassiano D Oliveira, Vanessa O Reis, Edgar Maquigussa, Ronaldo C Araújo, Tárcio T Braga, Maria F Soares, Ivan C Moura, Denise M A C Malheiros, Alvaro Pacheco-Silva Filho, Alexandre C Keller, Niels O S Câmara. Bradykinin receptor 1 activation exacerbates experimental focal and segmental glomerulosclerosis. Kidney international. 2011 Jun; 79(11):1217-27. doi: 10.1038/ki.2011.14. [PMID: 21412216]
  • Rocio Bautista-Pérez, Abraham Arellano, Martha Franco, Horacio Osorio, Israel Coronel. Enalaprilat-mediated activation of kinin b(1) receptors and vasodilation in the rat isolated perfused kidney. Pharmacology. 2011; 87(3-4):195-203. doi: 10.1159/000324513. [PMID: 21430409]
  • Fabiana N Dornelles, Diógenes S Santos, Thomas E Van Dyke, João B Calixto, Eraldo L Batista, Maria M Campos. In vivo up-regulation of kinin B1 receptors after treatment with Porphyromonas gingivalis lipopolysaccharide in rat paw. The Journal of pharmacology and experimental therapeutics. 2009 Sep; 330(3):756-63. doi: 10.1124/jpet.109.155762. [PMID: 19561153]
  • W Gary Anderson, Jérôme Leprince, J Michael Conlon. Purification, structural characterization, and myotropic activity of a peptide related to des-Arg(9)-bradykinin from an elasmobranch fish, the little skate, Leucoraja erinacea. Peptides. 2008 Aug; 29(8):1280-6. doi: 10.1016/j.peptides.2008.04.006. [PMID: 18502540]
  • M Abdouh, S Talbot, R Couture, H M Hasséssian. Retinal plasma extravasation in streptozotocin-diabetic rats mediated by kinin B(1) and B(2) receptors. British journal of pharmacology. 2008 May; 154(1):136-43. doi: 10.1038/bjp.2008.48. [PMID: 18311190]
  • Anik Désormeaux, Marie Eve Moreau, Yves Lepage, Jacques Chanard, Albert Adam. The effect of electronegativity and angiotensin-converting enzyme inhibition on the kinin-forming capacity of polyacrylonitrile dialysis membranes. Biomaterials. 2008 Mar; 29(9):1139-46. doi: 10.1016/j.biomaterials.2007.11.019. [PMID: 18078988]
  • Eduardo B Oliveira, Laura L Souza, Disney O Sivieri, Luiz B Bispo-da-Silva, Hugo J V Pereira, Claudio M Costa-Neto, Marcelo V Sousa, Maria Cristina O Salgado. Carboxypeptidase B and other kininases of the rat coronary and mesenteric arterial bed perfusates. American journal of physiology. Heart and circulatory physiology. 2007 Dec; 293(6):H3550-7. doi: 10.1152/ajpheart.00784.2007. [PMID: 17906107]
  • Jon E Hawkinson, Balazs G Szoke, Albert W Garofalo, Dennis S Hom, Hongbing Zhang, Mark Dreyer, Juri Y Fukuda, Linda Chen, Bhushan Samant, Stellanie Simmonds, Karla P Zeitz, Angie Wadsworth, Anna Liao, Raymond A Chavez, Wes Zmolek, Lany Ruslim, Michael P Bova, Ryan Holcomb, Eduardo R Butelman, Mei-Chuan Ko, Annika B Malmberg. Pharmacological, pharmacokinetic, and primate analgesic efficacy profile of the novel bradykinin B1 Receptor antagonist ELN441958. The Journal of pharmacology and experimental therapeutics. 2007 Aug; 322(2):619-30. doi: 10.1124/jpet.107.120352. [PMID: 17470643]
  • G Molinaro, Q L Duan, M Chagnon, M E Moreau, P Simon, P Clavel, S Lavaud, G Boileau, G A Rouleau, Y Lepage, A Adam, J Chanard. Kinin-dependent hypersensitivity reactions in hemodialysis: metabolic and genetic factors. Kidney international. 2006 Nov; 70(10):1823-31. doi: 10.1038/sj.ki.5001873. [PMID: 17003818]
  • Ronaldo C Araújo, Marcelo A Mori, Vanessa F Merino, Jean-Loup Bascands, Joost P Schanstra, Ricardo L Zollner, Conceição A Villela, Clovis R Nakaie, Antonio C M Paiva, Jorge L Pesquero, Michael Bader, João B Pesquero. Role of the kinin B1 receptor in insulin homeostasis and pancreatic islet function. Biological chemistry. 2006 Apr; 387(4):431-6. doi: 10.1515/bc.2006.057. [PMID: 16606341]
  • Ana C C Rocha, Elizabeth S Fernandes, Giselle F Passos, João B Calixto, Maria M Campos. Assessment of TNFalpha contribution to the functional up-regulation of kinin B(1) receptors in the mouse paw after treatment with LPS. International immunopharmacology. 2005 Oct; 5(11):1593-600. doi: 10.1016/j.intimp.2005.04.007. [PMID: 16039549]
  • Bichoy H Gabra, Pierre Sirois. Hyperalgesia in non-obese diabetic (NOD) mice: a role for the inducible bradykinin B1 receptor. European journal of pharmacology. 2005 May; 514(1):61-7. doi: 10.1016/j.ejphar.2005.03.018. [PMID: 15878325]
  • Donald M Arnold, Giuseppe Molinaro, Theodore E Warkentin, Julie DiTomasso, Kathryn E Webert, Ian Davis, Lawrence Lesiuk, Geoffrey Dunn, Nancy M Heddle, Albert Adam, Morris A Blajchman. Hypotensive transfusion reactions can occur with blood products that are leukoreduced before storage. Transfusion. 2004 Sep; 44(9):1361-6. doi: 10.1111/j.0041-1132.2004.04057.x. [PMID: 15318862]
  • Anthony C Sulpizio, Mark A Pullen, Richard M Edwards, David P Brooks. The effect of acute angiotensin-converting enzyme and neutral endopeptidase 24.11 inhibition on plasma extravasation in the rat. The Journal of pharmacology and experimental therapeutics. 2004 Jun; 309(3):1141-7. doi: 10.1124/jpet.103.064105. [PMID: 14769834]
  • Danielle R Santos, João B Calixto, Glória E P Souza. Effect of a kinin B2 receptor antagonist on LPS- and cytokine-induced neutrophil migration in rats. British journal of pharmacology. 2003 May; 139(2):271-8. doi: 10.1038/sj.bjp.0705236. [PMID: 12770932]
  • Aiguo Ni, Hang Yin, Jun Agata, Zhirong Yang, Lee Chao, Julie Chao. Overexpression of kinin B1 receptors induces hypertensive response to des-Arg9-bradykinin and susceptibility to inflammation. The Journal of biological chemistry. 2003 Jan; 278(1):219-25. doi: 10.1074/jbc.m209490200. [PMID: 12411434]
  • Steffen Sandmann, Elena Kaschina, Annegret Blume, Marie Luise Kruse, Thomas Unger. Bradykinin B1 and B2 receptors differentially regulate cardiac Na+-H+ exchanger, Na+-Ca2+ exchanger and Na+-HCO3- symporter. European journal of pharmacology. 2003 Jan; 458(1-2):3-16. doi: 10.1016/s0014-2999(02)02656-0. [PMID: 12498901]
  • Julie Christopher, Ayad A Jaffa. Diabetes modulates the expression of glomerular kinin receptors. International immunopharmacology. 2002 Dec; 2(13-14):1771-9. doi: 10.1016/s1567-5769(02)00188-1. [PMID: 12489791]
  • Giuseppe Molinaro, Albert Adam, Yves Lepage, Dale Hammerschmidt, Ulrike Koenigbauer, Ted Eastlund. Hypotensive reaction during staphylococcal protein A column therapy in a patient with anomalous degradation of bradykinin and Des-Arg9-bradykinin after contact activation. Transfusion. 2002 Nov; 42(11):1458-65. doi: 10.1046/j.1537-2995.2002.00196.x. [PMID: 12421219]
  • Giuseppe Molinaro, Massimo Cugno, Mélissa Perez, Yves Lepage, Nicole Gervais, Angelo Agostoni, Albert Adam. Angiotensin-converting enzyme inhibitor-associated angioedema is characterized by a slower degradation of des-arginine(9)-bradykinin. The Journal of pharmacology and experimental therapeutics. 2002 Oct; 303(1):232-7. doi: 10.1124/jpet.102.038067. [PMID: 12235256]
  • Rivaldo Niero, Ricardo Vieira Alves, Valdir Cechinel Filho, João Batista Calixto, Jane E Hawkes, Antonio Euzébio Sant'Ana, Rosendo Augusto Yunes. A new anti-oedematogenic nor-pregnane derivative isolated from Mandevilla illustris. Planta medica. 2002 Sep; 68(9):850-3. doi: 10.1055/s-2002-34409. [PMID: 12357405]
  • Giuseppe Molinaro, Nicole Gervais, Albert Adam. Biochemical basis of angioedema associated with recombinant tissue plasminogen activator treatment: an in vitro experimental approach. Stroke. 2002 Jun; 33(6):1712-6. doi: 10.1161/01.str.0000017284.77838.87. [PMID: 12053016]
  • Claude Braun, Thomas Kleemann, Ulrich Hilgenfeldt, Udo Riester, Peter Rohmeiss, Fokko J van der Woude. Activity and functional significance of the renal kallikrein-kinin-system in polycystic kidney disease of the rat. Kidney international. 2002 Jun; 61(6):2149-56. doi: 10.1046/j.1523-1755.2002.00385.x. [PMID: 12028455]
  • Izumi Hayashi, Hideki Amano, Keiko Ishihara, Yuji Kumagai, Hirokuni Yoshimura, Masataka C Majima. The role of kinin B1 in the plasma extravasation of carrageenin-induced pleurisy. Life sciences. 2002 Jan; 70(8):937-49. doi: 10.1016/s0024-3205(01)01460-6. [PMID: 11853231]
  • M Cyr, Y Lepage, C Blais, N Gervais, M Cugno, J L Rouleau, A Adam. Bradykinin and des-Arg(9)-bradykinin metabolic pathways and kinetics of activation of human plasma. American journal of physiology. Heart and circulatory physiology. 2001 Jul; 281(1):H275-83. doi: 10.1152/ajpheart.2001.281.1.h275. [PMID: 11406494]
  • I Duka, E Kintsurashvili, I Gavras, C Johns, M Bresnahan, H Gavras. Vasoactive potential of the b(1) bradykinin receptor in normotension and hypertension. Circulation research. 2001 Feb; 88(3):275-81. doi: 10.1161/01.res.88.3.275. [PMID: 11179194]
  • Joost P Schanstra, Maria E Marin-Castaño, Françoise Praddaude, Ivan Tack, Jean-Louis Ader, Jean-Pierre Girolami, Jean-Loup Bascands, Benoit Jeunier. Bradykinin B(1) receptor-mediated changes in renal hemodynamics during endotoxin-induced inflammation. Journal of the American Society of Nephrology : JASN. 2000 Jul; 11(7):1208-1215. doi: 10.1681/asn.v1171208. [PMID: 10864576]
  • C Lagneux, M Joyeux, G Bricca, P Demenge, C Ribuot. Hypertension in transgenic (mREN2)27 rats is not associated with the presence of B1 receptors. Fundamental & clinical pharmacology. 2000 Mar; 14(2):119-23. doi: 10.1111/j.1472-8206.2000.tb00399.x. [PMID: 10796058]
  • A Adam, C Blais, G Loute. [Kinins: their nature and their potential role in the cardiovascular effects of angiotensin-converting enzyme inhibitors]. Nephrologie. 2000; 21(4):163-72. doi: NULL. [PMID: 10976431]
  • K Bagaté, L Develioglu, J L Imbs, B Michel, J J Helwig, M Barthelmebs. Vascular kinin B(1) and B(2) receptor-mediated effects in the rat isolated perfused kidney - differential regulations. British journal of pharmacology. 1999 Dec; 128(8):1643-50. doi: 10.1038/sj.bjp.0702961. [PMID: 10588918]
  • H Naraba, A Ueno, M Yoshimura, Y Kosugi, S Oh-ishi. Examination of signal transduction pathway of stimulated B1 and B2 kinin receptors; MAP kinase pathway to AP-1 translocation in HEK 293 cells. Immunopharmacology. 1999 Dec; 45(1-3):35-8. doi: 10.1016/s0162-3109(99)00055-7. [PMID: 10614987]
  • C Blais, J L Rouleau, N J Brown, Y Lepage, D Spence, C Munoz, J Friborg, D Geadah, N Gervais, A Adam. Serum metabolism of bradykinin and des-Arg9-bradykinin in patients with angiotensin-converting enzyme inhibitor-associated angioedema. Immunopharmacology. 1999 Sep; 43(2-3):293-302. doi: 10.1016/s0162-3109(99)00133-2. [PMID: 10596866]
  • C Blais, A Adam, D Massicotte, F Péronnet. Increase in blood bradykinin concentration after eccentric weight-training exercise in men. Journal of applied physiology (Bethesda, Md. : 1985). 1999 Sep; 87(3):1197-201. doi: 10.1152/jappl.1999.87.3.1197. [PMID: 10484595]
  • C Mazenot, C Ribuot, P Demenge, D Godin-Ribuot. Monophosphoryl lipid A, a derivative of bacterial lipopolysaccharide, fails to induce B1-receptor-dependent responses to (des-Arg9)-bradykinin in the rabbit in vivo. Immunopharmacology. 1999 Feb; 41(2):165-8. doi: 10.1016/s0162-3109(98)00065-4. [PMID: 10102798]
  • C Blais, J Marc-Aurèle, W H Simmons, G Loute, P Thibault, R A Skidgel, A Adam. Des-Arg9-bradykinin metabolism in patients who presented hypersensitivity reactions during hemodialysis: role of serum ACE and aminopeptidase P. Peptides. 1999; 20(4):421-30. doi: 10.1016/s0196-9781(99)00020-0. [PMID: 10458510]
  • M E Marin-Castaño, J P Schanstra, F Praddaude, J B Pesquero, J L Ader, J P Girolami, J L Bascands. Differential induction of functional B1-bradykinin receptors along the rat nephron in endotoxin induced inflammation. Kidney international. 1998 Dec; 54(6):1888-98. doi: 10.1046/j.1523-1755.1998.00201.x. [PMID: 9853254]
  • R M Vianna, J B Calixto. Characterization of the receptor and the mechanisms underlying the inflammatory response induced by des-Arg9-BK in mouse pleurisy. British journal of pharmacology. 1998 Jan; 123(2):281-91. doi: 10.1038/sj.bjp.0701590. [PMID: 9489617]
  • P Rajasekariah, R S Warlow, R S Walls. High affinity bradykinin binding to human inflammatory cells. Biochemistry and molecular biology international. 1997 Oct; 43(2):279-90. doi: 10.1080/15216549700204061. [PMID: 9350335]
  • B S Dixon, M J Dennis. Interaction of kinins and captopril in regulating arterial smooth muscle cell proliferation. Kidney international. Supplement. 1997 Oct; 61(?):S14-7. doi: NULL. [PMID: 9328956]
  • P J Farmer, A Lepage, J G O'Brien, C F Bélanger, B Battistini, G E Plante, D Regoli, P Sirois. DesArg9BK increases the permeability of bovine aortic endothelial monolayer to iodinated albumin. Inflammation research : official journal of the European Histamine Research Society ... [et al.]. 1997 Aug; 46 Suppl 2(?):S149-50. doi: 10.1007/s000110050149. [PMID: 9297555]
  • A Décarie, P Raymond, N Gervais, R Couture, A Adam. Serum interspecies differences in metabolic pathways of bradykinin and [des-Arg9]BK: influence of enalaprilat. The American journal of physiology. 1996 Oct; 271(4 Pt 2):H1340-7. doi: 10.1152/ajpheart.1996.271.4.h1340. [PMID: 8897926]
  • H Cambridge, S D Brain. Mechanism of bradykinin-induced plasma extravasation in the rat knee joint. British journal of pharmacology. 1995 Jun; 115(4):641-7. doi: 10.1111/j.1476-5381.1995.tb14980.x. [PMID: 7582484]
  • P Raymond, G Drapeau, R Raut, R Audet, F Marceau, H Ong, A Adam. Quantification of des-Arg9-bradykinin using a chemiluminescence enzyme immunoassay: application to its kinetic profile during plasma activation. Journal of immunological methods. 1995 Mar; 180(2):247-57. doi: 10.1016/0022-1759(94)00320-v. [PMID: 7714339]
  • H L Pan, G L Stahl, S V Rendig, O A Carretero, J C Longhurst. Endogenous BK stimulates ischemically sensitive abdominal visceral C fiber afferents through kinin B2 receptors. The American journal of physiology. 1994 Dec; 267(6 Pt 2):H2398-406. doi: 10.1152/ajpheart.1994.267.6.h2398. [PMID: 7810739]
  • W Wang, D F Hendriks, S L Scharpé. Immobilized carboxypeptidase N. A potent bioreactor and specific adsorbent for peptides. Applied biochemistry and biotechnology. 1994 Feb; 44(2):151-60. doi: 10.1007/bf02921652. [PMID: 8017900]
  • C E Odya, R J Carlin, R D Yapa, B Soltani-Tehrani. Immunoassays for des-Arg9-bradykinin. Journal of immunoassay. 1993 Dec; 14(4):227-40. doi: 10.1080/15321819308019852. [PMID: 8294567]
  • J L Bascands, C Pecher, S Rouaud, C Emond, J L Tack, M J Bastie, R Burch, D Regoli, J P Girolami. Evidence for existence of two distinct bradykinin receptors on rat mesangial cells. The American journal of physiology. 1993 Mar; 264(3 Pt 2):F548-56. doi: 10.1152/ajprenal.1993.264.3.f548. [PMID: 8384416]
  • C M Munoz, S Cotecchia, L M Leeb-Lundberg. B2 kinin receptor-mediated internalization of bradykinin in DDT1 MF-2 smooth muscle cells is paralleled by sequestration of the occupied receptors. Archives of biochemistry and biophysics. 1993 Mar; 301(2):336-44. doi: 10.1006/abbi.1993.1153. [PMID: 8384832]
  • O Ljunggren, B B Fredholm, C Nordstedt, S Ljunghall, U H Lerner. Role of protein kinase C in bradykinin-induced prostaglandin formation in osteoblasts. European journal of pharmacology. 1993 Jan; 244(2):111-7. doi: 10.1016/0922-4106(93)90015-2. [PMID: 8432308]
  • C Shima, M Majima, M Katori. A stable metabolite, Arg-Pro-Pro-Gly-Phe, of bradykinin in the degradation pathway in human plasma. Japanese journal of pharmacology. 1992 Oct; 60(2):111-9. doi: 10.1254/jjp.60.111. [PMID: 1479739]
  • R Chahine, A Adam, N Yamaguchi, R Nadeau. Effects of bradykinin and Des-Arg9-bradykinin on the ischemic rat heart. Agents and actions. Supplements. 1992; 38 ( Pt 3)(?):103-9. doi: ". [PMID: 1462852]
  • M Issandou, J M Darbon. Des-Arg9 bradykinin modulates DNA synthesis, phospholipase C, and protein kinase C in cultured mesangial cells. Distinction from effects of bradykinin. The Journal of biological chemistry. 1991 Nov; 266(31):21037-43. doi: 10.1016/s0021-9258(18)54817-1. [PMID: 1939151]
  • M Sugihara, K Todoki, E Okabe. [The contractile response of isolated lingual arteries from rabbits treated with bacterial lipopolysaccharide via the stimulation of B1-receptors for kinins]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica. 1991 Aug; 98(2):63-71. doi: 10.1254/fpj.98.2_63. [PMID: 1916544]
  • L Churchill, J A Pongracic, C J Reynolds, R M Naclerio, D Proud. Pharmacology of nasal provocation with bradykinin: studies of tachyphylaxis, cyclooxygenase inhibition, alpha-adrenergic stimulation, and receptor subtype. International archives of allergy and applied immunology. 1991; 95(4):322-31. doi: 10.1159/000235469. [PMID: 1660035]
  • H Ishida, A G Scicli, O A Carretero. Contributions of various rat plasma peptidases to kinin hydrolysis. The Journal of pharmacology and experimental therapeutics. 1989 Dec; 251(3):817-20. doi: . [PMID: 2557417]
  • I A Sheikh, A P Kaplan. Assessment of kininases in rheumatic diseases and the effect of therapeutic agents. Arthritis and rheumatism. 1987 Feb; 30(2):138-45. doi: 10.1002/art.1780300203. [PMID: 3030335]
  • J B Calixto, R A Yunes. Effect of a crude extract of Mandevilla velutina on contractions induced by bradykinin and [des-Arg9]-bradykinin in isolated vessels of the rabbit. British journal of pharmacology. 1986 Aug; 88(4):937-41. doi: 10.1111/j.1476-5381.1986.tb16269.x. [PMID: 3742164]
  • I A Sheikh, A P Kaplan. Studies of the digestion of bradykinin, lysyl bradykinin, and kinin-degradation products by carboxypeptidases A, B, and N. Biochemical pharmacology. 1986 Jun; 35(12):1957-63. doi: 10.1016/0006-2952(86)90727-6. [PMID: 3718539]
  • I A Sheikh, A P Kaplan. Studies of the digestion of bradykinin, Lys-bradykinin, and des-Arg9-bradykinin by angiotensin converting enzyme. Biochemical pharmacology. 1986 Jun; 35(12):1951-6. doi: 10.1016/0006-2952(86)90726-4. [PMID: 3013204]
  • L Churchill, J C McGiff, P E Ward. Action and metabolism of des(Arg)kinins in mesenteric arteries. Advances in experimental medicine and biology. 1986; 198 Pt A(?):571-5. doi: 10.1007/978-1-4684-5143-6_76. [PMID: 3812095]
  • G Oshima, Y Hiraga, K Shirono, S Oh-ishi, S Sakakibara, T Kinoshita. Cleavage of des-Arg9-bradykinin by angiotensin I-converting enzyme from pig kidney cortex. Experientia. 1985 Mar; 41(3):325-8. doi: 10.1007/bf02004493. [PMID: 2982643]
  • C E Odya, F P Wilgis, J F Walker, S Oparil. Immunoreactive bradykinin and [des-Arg9]-bradykinin in low-renin essential hypertension--before and after treatment with enalapril (MK 421). The Journal of laboratory and clinical medicine. 1983 Nov; 102(5):714-21. doi: . [PMID: 6313833]
  • C E Odya, P Moreland, J M Stewart, J Barabe, D C Regoli. Development of a radioimmunoassay for [DES-ARG9]-bradykinin. Biochemical pharmacology. 1983 Jan; 32(2):337-42. doi: 10.1016/0006-2952(83)90564-6. [PMID: 6870961]
  • F Marceau, M Gendreau, J Barabé, S St-Pierre, D Regoli. The degradation of bradykinin (BK) and of des-Arg9-BK in plasma. Canadian journal of physiology and pharmacology. 1981 Feb; 59(2):131-8. doi: 10.1139/y81-022. [PMID: 7225939]